MedPath

Evaluation Effect of Folic Acid on Nocturnal Enuresis.

Phase 3
Conditions
Primary nocturnal enuresis.
Nocturnal enuresis
N39.44
Registration Number
IRCT20130518013366N14
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

Children with primary enuresis
Age more than 5 years of age
Satisfaction to participate in the study

Exclusion Criteria

History of enuresis
Receive enuresis-related treatments

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Frequency of nocturnal enuresis. Timepoint: Before treatment and 2 months after starting treatment. Method of measurement: Based on checklist.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath